Abstract

BackgroundMolecular epidemiological studies of Mycobacterium tuberculosis (MTB) are the core of current research to find out the association of the M. tuberculosis genotypes with its outbreak and transmission. The high prevalence of the Beijing genotype strain among multidrug resistance (MDR) TB has already been reported in various studies around India. The overall objective of this study was to detect the prevalence of Beijing genotype strains of MDR M. tuberculosis and their association with the clinical characteristics of TB patients.MethodsIn this study 381 M. tuberculosis clinical isolates were obtained from sputum samples from 2008 to 2014. The multiplex-PCR and Spoligotyping (n = 131) methods were used to investigate the prevalence of the Beijing genotype strain by targeting the Rv2820 gene and their association with drug resistance and clinical characteristics of TB patients. The drug susceptibility testing of first-line anti-TB drugs was performed by using the proportion method and MGIT960. A collection of isolates having Beijing and non-Beijing strains were also characterized to see if Beijing genotype strains had a higher rate of mutations at codons 516, 526 and 531 of the 81-bp region of the rpoB gene, codon 315 of the katG gene, and codon 306 of the embB gene.ResultsThe sensitivities and specificities of multiplex-PCR assay compared to that of standard Spoligotyping was detected to be 100%. Further, we observe that the multi drug-resistance was significantly associated with Beijing genotype strains (p = 0.03) and a strong correlation between Beijing genotype strains and specific resistance mutations at the katG315, rpoB531, and embB306 codons (p = < 0.0001, < 0.0001 & 0.0014 respectively) was also found.ConclusionsThis rapid, simple, and cost-effective multiplex PCR assay can effectively be used for monitoring the prevalence of Beijing genotype strains in low resource settings. Findings of this study may provide a scientific basis for the development of new diagnostic tools for detection and effective management of DR-TB in countries with a higher incidence rate of Beijing genotype strains.

Highlights

  • Molecular epidemiological studies of Mycobacterium tuberculosis (MTB) are the core of current research to find out the association of the M. tuberculosis genotypes with its outbreak and transmission

  • We characterized a collection of MTB patient isolates to see if the Beijing genotype strain had a higher rate of mutations at the katG315 codon, the rpoB516, rpoB526, and rpoB531 codons of Rifampicin resistance determining region (RRDR) region which accounts for > 95% of resistance to rifampicin (RIF), and embB306, which is responsible for resistance to ethambutol (EMB) [7, 8]

  • We found a 100% agreement between multiplex-PCR targeting the Rv2820 gene and standard spoligotyping for the detection of Beijing genotype strains of MTB

Read more

Summary

Introduction

Molecular epidemiological studies of Mycobacterium tuberculosis (MTB) are the core of current research to find out the association of the M. tuberculosis genotypes with its outbreak and transmission. The overall objective of this study was to detect the prevalence of Beijing genotype strains of MDR M. tuberculosis and their association with the clinical characteristics of TB patients. As a part of our overall objective we have attempted to assess the prevalence of Beijing genotype MTB strain and its relation to drug resistance and clinical characteristics of TB patients in North India. We characterized a collection of MTB patient isolates to see if the Beijing genotype strain had a higher rate of mutations at the katG315 codon, the rpoB516, rpoB526, and rpoB531 codons of RRDR region which accounts for > 95% of resistance to rifampicin (RIF), and embB306, which is responsible for resistance to ethambutol (EMB) [7, 8]. We have evaluated a multiplex PCR against standard spoligotyping for the rapid and cost-effective detection of Beijing genotypes of MTB strains

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call